91九色视频

header-logo
GettyImages-609179959-hero
Medicine
Ann Nattinger, MD

Ann B. Nattinger, MD, MPH

Associate Provost for Research; Senior Associate Dean for Research, School of Medicine; Professor of Medicine, Lady Riders Professor of Breast Cancer Research; Principal Investigator, CHDS

Locations

  • Office of Research
    MFRC #3102

Contact Information

General Interests

Breast Cancer Health Services, Variations in Cancer Treatment & Follow-up Care, Disparities in Care by Race and Socioeconomic Status, and Cancer Survivorship Issues

Biography

Ann B. Nattinger, MD, MPH, MACP, is Associate Provost for Research; Senior Associate Dean for Research, School of Medicine; Professor of Medicine, Lady Riders Professor of Breast Cancer Research; Principal Investigator, CHDS at the 91九色视频 in Milwaukee. Dr. Nattinger is a nationally recognized breast cancer health services researcher. She studies variations in cancer treatment and follow-up care, disparities in care by race and socioeconomic status, and cancer survivorship issues. Her work, funded mostly by the National Cancer Institute, has been published in leading journals, such as New England Journal of Medicine, Lancet, and JAMA. As Founding Director of the 91九色视频 Center for Patient Care and Outcomes Research (now Center for Advancing Population Science), Dr. Nattinger developed a college-wide interdisciplinary group of health services and disparities researchers. Until 2016, she was Chief of General Internal Medicine. In this capacity, she developed new hospitalist and perioperative programs and led 100 faculty members. As Associate Provost since 2016, she oversees the entire portfolio of research for 91九色视频. She has assisted 91九色视频 in developing a comprehensive plan for research growth and innovation. In addition, she leads the research infrastructure, including all related regulatory offices. She is a Master of the American College of Physicians and has served as President of the Society of General Internal Medicine.

Publications

  • (Bickell NA, Nattinger AB, McGinley EL, Schymura MJ, Laud PW, Pezzin LE.) J Clin Oncol. 2025 Jan;43(1):57-64 PMID: 39348624 PMCID: PMC11663124 09/30/2024

  • (Dong Y, Drury R, Spillane J, Lodes MW, Penlesky AC, Hanson R, Pezzin LE, Singh S, Nattinger AB.) J Gen Intern Med. 2024 Oct 02 PMID: 39358501 SCOPUS ID: 2-s2.0-85205436460 10/03/2024

  • (Rademacher N, Zhou Y, McGinley EL, Laud PW, Yen TWF, Ponce SB, Nattinger AB, Beyer KMM.) Cancer Med. 2024 Jul;13(14):e7397 PMID: 39030995 PMCID: PMC11258551 SCOPUS ID: 2-s2.0-85199018217 07/20/2024

  • (Spellecy R, Thompson N, Nattinger AB.) Ann Intern Med. 2024 Mar;177(3):383-384 PMID: 38346309 SCOPUS ID: 2-s2.0-85188479399 02/12/2024

  • (Dong Y, Hanson R, Penlesky AC, Nattinger AB, Heinrich TW, Pezzin LE.) WMJ. 2023 Dec;122(5):319-324 PMID: 38180917 SCOPUS ID: 2-s2.0-85181629574 01/05/2024

  • (Penlesky AC, Dunn C, Hanson R, Lodes M, Nattinger AB, Singh S.) WMJ. 2023 Dec;122(5):346-348 PMID: 38180922 SCOPUS ID: 2-s2.0-85181632740 01/05/2024

  • (Farkas AH, Nattinger AB.) Ann Intern Med. 2023 Nov;176(11):ITC161-ITC176 PMID: 37956433 SCOPUS ID: 2-s2.0-85178498893 11/13/2023

  • (Singh S, Laud PW, Crotty BH, Nanchal RS, Hanson R, Penlesky AC, Fletcher KE, Stadler ME, Dong Y, Nattinger AB.) Am J Med Qual. 2023 Sep-Oct 01;38(5):229-237 PMID: 37678301 SCOPUS ID: 2-s2.0-85170151971 09/08/2023

  • (Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE.) J Clin Oncol. 2023 Apr 10;41(11):2067-2075 PMID: 36603178 PMCID: PMC10419674 SCOPUS ID: 2-s2.0-85152169276 01/06/2023

  • (Braun EJ, Singh S, Penlesky AC, Strong EA, Holt JM, Fletcher KE, Stadler ME, Nattinger AB, Crotty BH.) BMJ Qual Saf. 2022 Oct;31(10):716-724 PMID: 35428684 SCOPUS ID: 2-s2.0-85128972108 04/17/2022

  • (Sanchez AM, Busse K, MacKinnon K, Henk L, MacKinnon GE, Brown J, Mauermann S, Dobrowski T, Jungmann J, Bultman J, Singh S, Nattinger AB.) WMJ. 2021 Dec;120(4):305-308 PMID: 35025179 SCOPUS ID: 2-s2.0-85123461368 01/14/2022

  • (Rivera F, Gmehlin CG, Pezzin LE, Hanson R, Perez A, Singh S, Ledeboer NA, Buchan BW, Nattinger AB, Munoz-Price LS.) WMJ. 2021 Dec;120(4):301-304 PMID: 35025178 SCOPUS ID: 2-s2.0-85123460891 01/14/2022

Publications of from the

© 2024 91九色视频.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.